Renal Cancer
Late Survival and Long-Term Follow-Up After Radical Resection of Advanced Renal Cell Carcinoma With Associated Venous Tumor Thrombus.
December 2, 2024
Comparison of outcomes between single-port and multi-port robotic radical nephrectomy.
November 29, 2024
Adverse events after nivolumab and ipilimumab combined immunotherapy in advanced renal cell carcinoma: a multicentre experience in Poland.
November 29, 2024
Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma.
November 28, 2024
Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study.
November 27, 2024
Papillary renal cell carcinoma revisited: impact of the World Health Organization 2022 classification on prognostication.
November 27, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Management of kidney cancer.
November 26, 2024
CD70: An Emerging Anticancer Target in Renal Cell Carcinoma and Beyond.
November 25, 2024
Risk factors for kidney cancer and socio-occupational category: significant impact of chlorinated solvents (UroCCR 111).
November 25, 2024
Robot-assisted partial nephrectomy vs. percutaneous cryoablation for T1a renal tumors: a single-center retrospective analysis of outcomes and costs.
November 25, 2024
Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti-CTLA-4 in renal cell carcinoma.
November 22, 2024
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis.
November 22, 2024
Spontaneous regression of metastatic clear cell renal cell carcinoma: A report of a rare case and a review of the literature.
November 20, 2024